Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3747622014 | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3747623016 | Programmed cell death protein 1 inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3969299018 | PD-1 (programmed cell death protein 1) inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Is a | Substance with effector mechanism of action (substance) | false | Inferred relationship | Some | ||
Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Programmed cell death protein 1 inhibitor (disposition) | true | Inferred relationship | Some | ||
Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Is a | Substance with immune checkpoint inhibitor mechanism of action (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Cemiplimab | Is a | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
Pembrolizumab (substance) | Is a | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
Atezolizumab (substance) | Is a | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
Nivolumab (substance) | Is a | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
Product containing programmed cell death protein 1 inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some | 1 |
Dostarlimab | Is a | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some | |
Tislelizumab | Is a | True | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | Inferred relationship | Some |
This concept is not in any reference sets